014 Does TB treatment alter virological and immunological response to HAART?
G Dean(Royal Sussex County Hospital), Anton Pozniak, Chris Taylor(King's College Hospital), Annemiek de Ruiter(ViiV Healthcare (Spain)), Martin Fisher(Northwell Health), Gail Matthews(UNSW Sydney), G. P. Taylor(St Mary's Hospital), SG Edwards(Mortimer Market Centre), Dr Churchill(Royal Sussex County Hospital), Lesley Navaratne(St Thomas' Hospital), Cg Wood(North Middlesex Hospital), Ef Fox(St George's Hospital)
Cited by 0
Related Papers
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
|Nature Immunology|2022|987
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631